Evolution of the Average Target: W. P. Carey Inc.

Evolution of the Target Price: W. P. Carey Inc.

Changes in Analyst Recommendations: W. P. Carey Inc.

7.4C-aIFuSBdCQQZc7CCDLGQle7zzRT8VgyLp5s9Mx_cQ.v2bxUhLdZJuiM9ZSYBOidko2l1fkDIMJhflUyaVasL6NbclJH9FL6Kg71g~f8a5cbfaaf51776223b79e357aa11141
17/03 Raymond James Upgrades W. P. Carey to Outperform From Market Perform, Price Target is $76 MT
17/03 Analyst recommendations: Align Technology, Eli Lilly, Adobe, Salesforce… Zonebourse
09/03 UBS Adjusts Price Target on W. P. Carey to $75 From $68, Maintains Neutral Rating MT
12/02 RBC Lifts Price Target on W.P. Carey to $72 From $70, Keeps Sector Perform Rating MT
08/01 W. P. Carey Sees Strong Q4 Investment, Dispositions as Equity Largely Secured for 2026, RBC Says MT
08/01 RBC Lifts Price Target on W.P. Carey to $70 From $69, Keeps Sector Perform Rating MT
08/12 W. P. Carey's Growth Drivers to Have Smaller Impact in 2026, Equity Issuance a Risk, RBC Says MT
08/12 Analyst recommendations: 3M Company, Exxon Mobil, Mastercard, Netflix, Tesla… Zonebourse
08/12 RBC Downgrades W.P. Carey to Sector Perform From Outperform, Keeps $69 Price Target MT
12/25/12 W. P. Carey Shares Rise After Wells Fargo Upgrade MT
11/25/11 Wells Fargo Upgrades W. P. Carey to Overweight From Equalweight MT
15/25/15 UBS Raises Price Target on W. P. Carey to $68 From $63, Maintains Neutral Rating MT
09/25/09 BNP Paribas Exane Upgrades W. P. Carey to Neutral From Underperform MT
09/25/09 BNP Paribas Exane Upgrades W. P. Carey to Neutral From Underperform, Adjusts PT to $66 From $63 MT
09/25/09 Analyst recommendations: Broadcom, Lululemon, McDonald's, Tesla, Etsy… Zonebourse
13/25/13 UBS Adjusts Price Target on W. P. Carey to $63 From $66, Maintains Neutral Rating MT
01/25/01 RBC Raises Price Target on W.P. Carey to $66 From $62, Keeps Outperform Rating MT
18/25/18 BMO Capital Upgrades W. P. Carey to Outperform From Market Perform Perform, Adjusts Price Target to $67 From $60 MT
13/25/13 RBC Raises Price Target on W.P. Carey to $62 From $61, Keeps Outperform Rating MT
06/25/06 UBS Adjusts Price Target on W. P. Carey to $58 From $60, Keeps Neutral Rating MT
12/24/12 RBC Trims Price Target on W.P. Carey to $62 From $63, Keeps Outperform Rating MT
14/24/14 UBS Lowers W. P. Carey Price Target to $60 From $62, Maintains Neutral Rating MT
16/24/16 UBS Adjusts Price Target on W. P. Carey to $62 From $61, Maintains Neutral Rating MT
30/24/30 RBC Raises Price Target on W. P. Carey to $67 From $62, Keeps Outperform Rating MT
28/24/28 Evercore ISI Raises Price Target on W. P. Carey to $63 From $61, Maintains In Line Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+3.61%
+13.41%
+19.07%
+32.74%
+21.02%
+16.66%
+14.69%
+26.18%
Average +18.42%
Weighted average by Cap. +15.86%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
71.58USD
Average target price
74.17USD
Spread / Average Target
+3.61%
High Price Target
82.00USD
Spread / Highest target
+14.56%
Low Price Target
68.00USD
Spread / Lowest Target
-5.00%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Raymond James
UBS
RBC Capital Markets
Wells Fargo Securities
BNP Paribas Exane
BMO Capital
Barclays
Scotiabank
BofA Securities
Evercore ISI
JMP Securities
Citigroup
Wolfe Research
Capital One Securities
JPMorgan Chase
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
71.58USD
Average target price
74.17USD
Spread / Average Target
+3.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. WPC Stock
  4. Consensus W. P. Carey Inc.